Role of hypoxia-inducible factor in diabetic myocardial hypertrophy

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Purpose: This study was carried out to investigate the role of hypoxia-inducible factor (HIF) in diabetic cardiomyopathy in vitro. Methods: Hypoxia was induced chemically in H9C2 cells (cardiac hypertrophy model), and the cells were treated with phenylephrine (PE), deferoxamine (DFO), PE + DFO, and HIF-1α siRNA under conditions of high and normal glucose. Western blot was used to analyze the expression of some glycolytic proteins, including Glut-1, hexokinase (HXK-2), and enolase, while apoptosis of H9C2 was determined by flow cytometry. Results: PE caused hypertrophy in H9C2, which was ameliorated by HIF-1α. Compared to normal, under prolonged high glucose, the low expression of HIF-1α led to low expressions of Glut-1, HXK-2 and enolase. However, expression of HIF-1α decreased, while those of Bax and Caspase 3 increased, and Bcl-2 expression decreased. Furthermore, under short time high glucose, HIF-1α caused apoptosis of hypertrophic cardiomyocytes. Conclusion: HIF-1 mediates diabetic myocardial hypertrophy, probably as a function of the degree of high glucose exposure and hypoxia.

Cite

CITATION STYLE

APA

Qin, L., Xifa, S., Dawei, X., Yangjing, X., Kangting, J., Jian, X., & Suqin, Z. (2016). Role of hypoxia-inducible factor in diabetic myocardial hypertrophy. Tropical Journal of Pharmaceutical Research, 15(11), 2421–2427. https://doi.org/10.4314/tjpr.v15i11.17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free